PharmaLex

Mannheim, Germany Founded: 1998 • Age: 28 yrs Acquired By AmerisourceBergen
CRO specializing in regulatory affairs and pharmacovigilance
Annual revenue $7.5M Latest available
Total funding - 2 rounds
Employees 267 Tracked headcount
Investors 2 Known backers
Products 3 Services tracked
Competitors 10 Brand Intelligence

About PharmaLex

PharmaLex is a company based in Mannheim (Germany) founded in 1998 was acquired by AmerisourceBergen in September 2022. The company has 267 employees as of April 08, 2024. PharmaLex has completed 6 acquisitions, including Arbour Group, DRA and ERA Consulting. PharmaLex offers products and services including Strategic and Scientific Consultancy, Integrated Product Development, and Regulatory Affairs and CMC. PharmaLex operates in a competitive market with competitors including ProPharma Group, Validant, Technical Safety Services, Celegence and Pharma-Bio Serv, among others.

  • Headquarter Mannheim, Germany
  • Employees 267 as on 08 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Pharmalex India Private Limited
  • Date of Incorporation 23 May, 2013
  • Jurisdiction Delhi, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $7.47 M (USD)
    10.24
    as on Mar 31, 2023
  • Net Profit
    $814.77 K (USD)
    -39.79
    as on Mar 31, 2023
  • EBITDA
    $1.1 M (USD)
    -47.46
    as on Mar 31, 2023
  • Latest Funding Round
    $38.44 K (USD), Grant

    Jun 01, 2022

  • Investors
  • Employee Count
    267

    as on Apr 08, 2024

  • Investments & Acquisitions
  • Acquired by
    AmerisourceBergen

    & 1 more

    (Sep 12, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PharmaLex

PharmaLex offers a comprehensive portfolio of products and services, including Strategic and Scientific Consultancy, Integrated Product Development, and Regulatory Affairs and CMC.

Product name locked
Category locked
Primary

Provides strategic advice for pharmaceutical and biotech development.

Product name locked
Category locked
Locked

Offers end-to-end solutions for product innovation and market access.

Product name locked
Category locked
Locked

Manages compliance and regulatory writing for industry standards.

People of PharmaLex

Headcount 10-50
Employee Profiles 14
Employee Profiles
People
Juhi Mittal
Senior Manager, Statistics
People
Krishna Vemulapalli
Senior Specialist, Statistics
People
Bess Dalby
Manager, Data Science
People
Yilu Jin
Sr.Specialist, Statistics

Unlock access to complete

Funding Insights of PharmaLex

Investors in PharmaLex

PharmaLex has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include AmerisourceBergen and European Union.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Pharmaceutical distribution and supply chain services are provided globally.
Locked Locked Locked
Premium access

Investor details for PharmaLex

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by PharmaLex

PharmaLex has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Arbour Group, DRA and ERA Consulting.

Investments
Premium access

Investment portfolio details for PharmaLex

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Market access services are provided to the biopharma sector.
Locked Locked 2002 Locked
Natural gas is transported via pipelines from production to markets.
Locked Locked 2002 Locked
Regulatory compliance services are provided to businesses since 1995.
Locked Locked 1995 Locked
Premium access

Complete acquisition details for PharmaLex

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - PharmaLex

Premium access

Detailed financials for PharmaLex

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Pharmalex Comparisons

PharmaLex Primary company
Description
CRO specializing in regulatory affairs and pharmacovigilance
Location
Mannheim, Germany
Founded Year
1998
Annual Revenue
$7.47 M (USD)
Net Profit
$814.77 K (USD)
EBITDA
$1.1 M (USD)
Employees
267
As of 2024
Premium access

Peer comparison for PharmaLex

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of PharmaLex

PharmaLex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ProPharma Group, Validant, Technical Safety Services, Celegence and Pharma-Bio Serv, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device
Locked Locked Locked
Regulatory, compliance, and quality consulting for GxP lifecycles is provided.
Locked Locked Locked
Healthcare instrumentation, medical gas systems, and related devices are manufactured.
Locked Locked Locked
Regulatory consulting and solutions for pharmaceuticals and medical devices compliance.
Locked Locked Locked
Provider of regulatory compliance and validation support to life science industries
Premium access

Detailed competitors of PharmaLex

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Pharmalex

Premium access

Complete news archive for PharmaLex

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PharmaLex

PharmaLex was founded in 1998 and raised its 1st funding round 21 years after it was founded.

PharmaLex is headquartered in Mannheim, Germany. It is registered at Mannheim, Baden-wurttemberg, Germany.

As of Apr 08, 2024, the latest employee count at PharmaLex is 267.

Annual revenue of PharmaLex is $7.47M as on Mar 31, 2023.

PharmaLex was founded in 1998 and operates as a contract research organization in the pharmaceutical sector from Mannheim, Germany. The current entity was established in 2015 through the merger of YES Pharma and PharmaLex. Services encompass development consulting, scientific affairs including clinical trial design and CTD documents, regulatory affairs such as procedure management and electronic submissions, and pharmacovigilance covering risk management, signal detection, and ICSR processing.

PharmaLex's top competitors include ProPharma Group, Pharma-Bio Serv and Validant.

PharmaLex offers Strategic and Scientific Consultancy, Integrated Product Development, and Regulatory Affairs and CMC.

PharmaLex has made 6 acquisitions, including Arbour Group, DRA, and ERA Consulting.

PharmaLex has 2 investors. Key investors include AmerisourceBergen, and European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available